human embryonic stem cells | GenomeWeb

human embryonic stem cells

The collaboration between Columbia University and The Hebrew University suggests some surprising biology could improve loss-of-function genetic screening.

In Nucleic Acids Research this week: literature-mining method for uncovering additional gene-disease associations, database of human embryonic stem cell and induced pluripotent stem cell lines, and more.

NEW YORK (GenomeWeb) – Cellectis today announced it is selling its stem cell-focused subsidiary Cellectis AB to Takara Bio for an undisclosed amount.

NEW YORK (GenomeWeb News) – The National Institutes of Health Stem Cell Registry has approved 52 human embryonic stem cell lines from Genea Biocells, the Australian company said this week.

NEW YORK (GenomeWeb News) – Public interest groups Consumer Watchdog and the Public Patent Foundation said Tuesday that they have asked a federal appeals court to invalidate a patent held by the Wisconsin Alumni Research Foundation covering human embryonic stem cells.

Life Technologies this week announced the commercial availability of a pair of new PCR-related products for molecular biology research.

NEW YORK (GenomeWeb News) – A new study suggests a significant proportion of long, non-coding RNAs, or lncRNAs, are transcribed in cahoots with neighboring messenger RNAs in mammalian stem cells.

By Ben Butkus
Stanford University researchers have published a method for using Fluidigm's digital PCR platform to conduct single-cell, real-time PCR to compare gene expression patterns of single cells.

The firms intend to establish a bank of hESC lines using Advanced Cell's "single-ceblastomere" technique for deriving embryonic stem cells without damage to the embryo.


In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.